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Exploring the genome-wide roles of transcription factors and their
complexes in chromosome interaction. MJ. Li1,2, LY. Wang1, PC. Sham3,
MQ. Zhang4, JS. Liu2, JW. Wang1. 1) Biochemistry, The University of Hong
Kong, Hong Kong; 2) Statistics Dept, Harvard University, Boston, MA, USA;
3) Psychiatry Dept, The University of Hong Kong, Hong Kong; 4) Molecular
and Cell Biology Dept,, The University of Texas at Dallas, Dallas, TX, USA.
The tight regulation of genes in different cells is governed by temporal
and spatial biological signals. It is very important to pinpoint the pattern of
transcription factors (TFs) and their complexes in looping interactions and
to detect TF complexes as well as the underlying cis-regulatory modules
(CRMs) in different human cell types. Existing studies on analysis of TFs
and their complexes were only performed at one dimension and not at
genome-wide scale. Recently, the unbiased chromosome conformation cap-
ture, Hi-C, can detect the genome-wide chromatin interactions, but has
restrictions on its resolution due to the variable cell-to-cell chromosome
structures and inadequate sequencing depth. In this study, we provide a
comprehensive analysis on TFs regulatory pattern within chromosome loop-
ing by combining Hi-C and ENCODE ChIP-Seq data from three human cell
types (GM12878, H1-hESC and K562). We first devised a strategy to map
ChIP-Seq peaks of each TF to a normalized 10kb Hi-C contact matrix and
construct an interaction matrix for each participant TF. We observed tight
correlation for TFs participant activities in high resolution chromosome loop-
ing between biological replicates, which indicate the TF activities is more
stable than local DNA interactions. To check the enrichment of different
chromatin marks and genomic features in the interaction region of each
participant TF, we performed enrichment test on several histone modifica-
tions marks (H3K4me1, H3K4me2, H3K4me3, H3K27me3, H3K36me3,
H3K9ac, H3K27ac), CAGE, DHSs, DNA methylation (RRBS) and conserva-
tion signals. We found chromatin markers and genomic features of each
TF is highly correlated between replications. We also observed that grouped
TFs shared consistent patterns of chromatin marks and genomic features,
which indicate their similar roles in gene regulation. Furthermore, we devel-
oped a method to detect the candidate TF complexes by reducing the
dimension of huge sparse interaction matrix for each participant TF followed
by community clustering. We successfully detected several known com-
plexes mediating long range enhancer-promoter interaction in different cell
types. Using the combinatory motifs scanning, we can predict the genome-
wide CRMs for specific TF complex with known motifs. Finally, by correlating
gene expression profiles of TF and its targets , we can pinpoint the role of
detected TF complexes (active or repressive) in controlling cell type specific
gene regulation.
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Comparing blood and brain gene expression networks in Huntington's
Disease by semantic analysis. E. Mina, P.A.C. 't Hoen, W. van Roon-
Mom, M. Roos. Department of Human and Clinical Genetics, Leiden Univer-
sity Medical Center, Leiden, The Netherlands.
Huntington's Disease (HD) is a neurodegenerative disease with the most
prominent pathology in the brain. However, human brain tissue is not easily
accessible for molecular biology studies and it cannot be isolated from living
patients. The widespread pathology of HD indicates that the phenotype is not
limited to brain dysfunction. Several studies have shown that understanding
alterations in peripheral tissues could be valuable for monitoring disease
progression. Considering that transcriptome technologies have successfully
been used for biomarker discovery and the study of physiological and patho-
physiological mechanisms, it is evident that studying transcriptional changes
in peripheral tissue can provide new insights that can lead to the development
of new therapies and markers to monitor disease progression. In addition,
novel sequencing technologies and the wide availability of data and pub-
lished articles, create opportunities for novel, more effective ways of data
exploitation. Our methodology identifies and prioritizes disease signatures
from blood that are also associated with abnormalities in brain, in a robust
way by a combination of large scale network analysis, integration of hetero-
geneous datasets, and incorporation of prior knowledge mined from litera-
ture. Our preliminary data show that modules in gene co-expression net-
works are significantly more reproducible than individual gene markers
between blood and brain. We additionally link significant HD signatures to
biological and pharmacological knowledge sources to prioritize biomarkers
based on their potential as drug targets using a 'Linked Data' approach.
This allowed us to identify drug targets by querying across four different
data sources, including drugbank and pathway data to target pathways that
are impaired in HD. For instance, we found Imatinib, associated with the
gene ABL1 that targets autophagy and is known to delay production of beta-
amyloid. Moreover, in the HD context, we prioritize drug targets according
to their structural or functional similarity to known targets that can pass the
blood-brain barrier. In conclusion, our approach is a powerful method to
identify genes that are potentially involved in physiological and pathophysio-
logical processes in HD. Using the 'Linked Data' approach, our results can
be easily extended and will become available to the scientific community
as a resource for further investigation for understanding disease pathology
in HD.
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Genetic Risk Prediction and Neurobiological Understanding of Alco-
holism. A. Niculescu1, 12, D. Levey1, H. Le-Niculescu1, J. Frank2, M. Aya-
lew1, N. Jain1, B. Kirlin1, R. Learman1, E. Winiger1, Z. Rodd1, A. Shekhar1,
N. Schork3, F. Kiefer4, N. Wodarz5, B. Muller-Myhsok6, N. Dahmen7, M.
Nothen11, R. Sherva8, L. Farrer8, A. Smith9, H. Kranzler10, M. Rietschel2,
J. Gelernter9, GESGA Consortium. 1) Psychiatry, Indian Univ Sch Medicine,
Indianapolis, IN; 2) Central Institute of Mental Health, Mannheim, Germany;
3) Department of Human Biology, The J. Craig Venter Institute, La Jolla,
California, USA; 4) Dept. of Addictive Behavior and Addiction Medicine,
Central Institute of Mental Health, Medical Faculty Mannheim / Heidelberg
University. Germany; 5) Dept. of Psychiatry, University Medical Center
Regensburg, Univ. of Regensburg, Germany; 6) Dept. of Statistical Genetics,
Max-Planck-Institute of Psychiatry, Munich, Germany; 7) Dept. of Psychiatry,
Univ. of Mainz, Germany; 8) Boston University School of Medicine, Depart-
ment of Medicine (Biomedical Genetics); 9) Yale University School of Medi-
cine, Department of Psychiatry, Division of Human Genetics; and VA CT
Healthcare Center; 10) Department of Psychiatry, University of Pennsylvania
Perelman School of Medicine, and Philadelphia VAMC; 11) Dept. of Geno-
mics, Life & Brain Center, Univ. of Bonn; Inst. of Human Genetics, Univ. of
Bonn, Germany; 12) Indianapolis VA Medical Center, Indianapolis, Indi-
ana, USA.
We have used a translational convergent functional genomics (CFG)
approach to discover genes involved in alcoholism, by gene-level integration
of genome-wide association study (GWAS) data from a German alcohol
dependence cohort with other genetic and gene expression data, from
human and animal model studies, similar to our previous work in bipolar
disorder and schizophrenia. A panel of all the nominally significant p-value
SNPs in the top candidate genes discovered by CFG (n=135 genes, 713
SNPs) was used to generate a genetic risk prediction score (GRPS), which
showed a trend towards significance (p=0.053) in separating alcohol depend-
ent individuals from controls in an independent German test cohort. We
then validated and prioritized our top findings from this discovery work, and
subsequently tested them in three independent cohorts, from two continents.
In order to validate and prioritize the key genes that drive behavior without
some of the pleiotropic environmental confounds present in humans, we
used a stress-reactive animal model of alcoholism developed by our group,
the DBP knock-out mouse. A much smaller panel (n=11 genes, 66 SNPs)
of the top CFG-discovered genes for alcoholism, cross-validated and priori-
tized by this animal model, showed better predictive ability in the independent
German test cohort (p= 0.041). The top CFG scoring gene for alcoholism
from the initial discovery step, synuclein alpha (SNCA), remained the top
gene after the stress-reactive animal model cross-validation. We also tested
this small panel of genes in two other independent test cohorts from the
United States, one with alcohol dependence (p=0.00012), and one with
alcohol abuse (a less severe form of alcoholism) (p=0.0094). SNCA by itself
was able to separate alcoholics from controls in the alcohol dependent
cohort (p= 0.000013) and the alcohol abuse cohort (p= 0.023). So did 8
other genes from the panel of 11 genes taken individually, albeit to a lesser
extent and/or less broadly across cohorts. SNCA, GRM3 and MBP survived
strict Bonferroni correction for multiple comparisons. Taken together, these
results suggest that our stress-reactive DBP animal model helped to validate
and prioritize from the CFG-discovered genes some of the key behaviorally
relevant genes for alcoholism. These genes fall into a series of biological
pathways involved in signal transduction, transmission of nerve impulse
(including myelination), and cocaine addiction.
